Results 71 to 80 of about 18,622 (204)

Primary cardiovascular preventive effect of thiazolidinedione in adults with type 2 diabetes: A nationwide cohort study in Korea

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 8, Page 1367-1378, August 2026.
Among Korean adults with type 2 diabetes and no prior cardiovascular disease, thiazolidinedione use was associated with a lower risk of the primary composite outcome of stroke, myocardial infarction, hospitalization for heart failure, and all‐cause mortality compared to dipeptidyl peptidase‐4 inhibitor use. ABSTRACT Background Thiazolidinediones (TZDs)
Yun Young Choi   +4 more
wiley   +1 more source

Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin–Dipyridamole Combination Treatment in Melanoma Cell Lines

open access: yesBiomedicines
Metastatic melanoma has a very poor prognosis. Statins, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) inhibitors, are cholesterol-lowering agents with a potential for cancer treatment.
Nanami Irie   +9 more
doaj   +1 more source

Reverse redistribution on Rb-82: Does the mechanism of stress play a role?

open access: yesWorld Journal of Nuclear Medicine, 2019
We present a case of reverse redistribution in a patient imaged with Rb-82 positron-emitting tomography. The patient was imaged twice in rapid succession using pharmacological stress – once with dipyridamole and once with dobutamine.
Patrick Martineau   +2 more
doaj   +1 more source

eNOS Uncoupling, Shear‐Stress Tolerance, and the Two‐Threshold Model of Post‐Exertional Malaise in Long COVID: A Mechanistic Hypothesis With Implications for Physiotherapy and Recovery Protocols

open access: yesMicrocirculation, Volume 33, Issue 6, August 2026.
ABSTRACT Objective To propose and make testable a mechanistic hypothesis for post‐exertional malaise (PEM) in a clinically distinct subset of Long COVID patients, in whom delayed exertional symptoms coexist with consistently normal macrovascular investigations.
Yiannis K. Karipidis   +1 more
wiley   +1 more source

Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study

open access: yes, 2002
Pulse ischemia-dependent submaximal increase in adenosine levels in plasma and in the interstitium is believed to mediate the phenomenon of ischemic preconditioning of the heart, by the interaction with the specific A1 and A3 receptors on myocytes.
Antonio Cuomo   +13 more
core   +1 more source

Dipyridamole Acts as Clinical Ferroptosis Inhibitor to Prevent from Tissue Injury

open access: yesAdvanced Science
Ferroptosis is a newly identified cell death triggered by iron‐induced lipid peroxidation. Numerous studies reveal that ferroptosis participates in multiple types of tissue injury including ischaemia–reperfusion (I/R) injury and doxorubicin (Dox)‐induced
Xiao Zhuang   +22 more
doaj   +1 more source

Complications due to Stress Echocardiography

open access: yesОбщая реаниматология, 2007
Objective: to assess the prevalence of minor and major complications and side effects during stress echocardiography (stress-EchoCG) in a group of patients with suspected coronary heart disease (CHD).Subjects and methods: The study included 1359 patients
N. N. Mikheyev
doaj   +1 more source

Topic diagnostics of coronary pathology in coronary heart disease patients by contrast stress echocardiography with dipyridamole

open access: yesКардиоваскулярная терапия и профилактика, 2005
Aim. To assess diagnostic potential of contrast stress echocardiography (CS-EchoCG) with dipyridamole in coronary heart disease (CHD) patients. Material and methods. The study included 22 patients (mean age 56.04±1.8 years) with typical CHD clinics.
S. T. Matskeplishvili   +4 more
doaj  

Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets

open access: yes, 2002
Inhaled nitric oxide (NO) is increasingly used in the treatment of pulmonary hypertension, despite its potential toxicity and the risk of life-threatening rebound pulmonary hypertension upon its discontinuation. We investigated whether i.v. dipyridamole,
Van Nooten, Guido   +18 more
core   +1 more source

Evaluation of inhibitory effects of dipyridamole against bovine and equine piroplasmosis [PDF]

open access: yes, 2016
application/pdfDipyridamole, an antiplatelet drug used for the secondary prevention and treatment of stroke, also has antiplasmodial activity and enhances the activity of chloroquine.
Igarashi, Ikuo   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy